SEARCH

SEARCH BY CITATION

References

  • 1
    Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the national health and nutrition survey, 1999–2000. Circulation. 2004;110:738743.
  • 2
    Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension. 2007;49:981985.
  • 3
    Lacy PS, O'Brien DG, Stanley AG, et al. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens. 2004;22:19371944.
  • 4
    van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis. The Rotterdam study. Stroke. 2001;32:454460.
  • 5
    Nürnberger J, Dammer S, Saez AO, et al. Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males. J Hum Hypertens. 2003;17:153158.
  • 6
    Alecu C, Gueguen R, Salvi P, et al. Determinants of arterial stiffness in an apparently health population over 60 years. J Hum Hypertens. 2006;20:749756.
  • 7
    Lantelme P, Mestre C, Lievre M, et al. Heart rate: an important confounder of pulse wave velocity assessment. Hypertension. 2002;39:10831087.
  • 8
    Arnett DK, Evens GW, Riley WA. Arterial stiffness: a new cardiovascular risk factors? Am J Epidemiol. 1994;140:669682.
  • 9
    Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 5th ed. London: Hodder Arnold; 2005.
  • 10
    Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness. A systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:13181327.
  • 11
    Brewer LC, Chai HS, Bailey KR, Kullo IJ. Measures of arterial stiffness and wave reflection are associated with walking distance in patients with peripheral arterial disease. Atherosclerosis. 2007;191:384390.
  • 12
    Amoh-Tonto CA, Malik AR, Kondragunta V, et al. Brachial-ankle pulse wave velocity is associated with walking distance in patients referred for peripheral arterial disease evaluation. Atherosclerosis. 2009;206:173178.
  • 13
    Laurent S, Cockcroft J, van Bortel L, et al.; on behalf of the European network for Non-invasive investigation of large Arteries. Expert Consensus on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:25882605.
  • 14
    ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58:20202045.
  • 15
    Zagura M, Serg M, Kampus P, et al. Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral arterial disease and in healthy subjects. Am J Hypertens. 2010;23:586591.
  • 16
    Kals J, Zagura M, Serg M, et al. β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients. Scand J Clin Lab Invest. 2011;71:257263.
  • 17
    Laurent S. Surrogate measures of arterial stiffness: do they have additive predictive value or are they only surrogates of a surrogate? Hypertension. 2006;47:325326.
  • 18
    Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107:28642869.
  • 19
    O'Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45:652658.
  • 20
    Benetos A, Adamopoulos C, Bureau JM, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation. 2002;105:12021207.
  • 21
    Smith A, Karalliedde J, De Angelis L, et al. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16:10691075.
  • 22
    Safar ME, Laurent S, Asmar RG, et al. Systolic hypertension in patients with arteriosclerosis obliterans of the lower limbs. Angiology. 1987;38:287295.
  • 23
    Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54:13281336.
  • 24
    Ross R. Atherosclerosis an inflammatory disease. N Engl J Med. 1999;340:115126.
  • 25
    Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:24812485.
  • 26
    Yasmin, McEniery CM, Wallace S, et al. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol. 2004;24:969974.
  • 27
    Engstrom G, Janzon L, Berglund G, et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol. 2002;22:20542058.
  • 28
    Maki-Petaja KM, Wilkinson IB. Inflammation and large arteries: potential mechanisms for inflammation-induced arterial stiffness. Artery Research. 2012;6:5964.
  • 29
    Clancy P, Oliver L, Jayalath R, et al. Assessment of a serum assay for quantification of abdominal aortic calcification. Arterioscler Thromb Vasc Biol. 2006;26:25742576.
  • 30
    Mitchell GF, Vita JA, Larson MG, et al. Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham heart study. Circulation. 2005;112:37223728.
  • 31
    Safar ME, Totomoukouo JJ, Asmar RA, Laurent SM. Increased pulse pressure in patients with arteriosclerosis obliterans of the lower limbs. Arteriosclerosis. 1987;7:232237.
  • 32
    Ahimastos AA, Dart AM, Lawler A, et al. Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients. J Hypertens. 2008;26:10371042.